Early invasion of the bladder wall by solitary bacteria protects UPEC from antibiotics and neutrophil swarms in an organoid model
- PMID: 34289360
- DOI: 10.1016/j.celrep.2021.109351
Early invasion of the bladder wall by solitary bacteria protects UPEC from antibiotics and neutrophil swarms in an organoid model
Abstract
Recurrence of uropathogenic Escherichia coli (UPEC) infections has been attributed to reactivation of quiescent intracellular reservoirs (QIRs) in deep layers of the bladder wall. QIRs are thought to arise late during infection following dispersal of bacteria from intracellular bacterial communities (IBCs) in superficial umbrella cells. Here, we track the formation of QIR-like bacteria in a bladder organoid model that recapitulates the stratified uroepithelium within a volume suitable for high-resolution live-cell imaging. Bacteria injected into the organoid lumen enter umbrella-like cells and proliferate to form IBC-like bodies. In parallel, single bacteria penetrate deeper layers of the organoid wall, where they localize within or between uroepithelial cells. These "solitary" bacteria evade killing by antibiotics and neutrophils and are morphologically distinct from bacteria in IBCs. We conclude that bacteria with QIR-like properties may arise at early stages of infection, independent of IBC formation and rupture.
Keywords: IBCs; QIRs; UPEC; antibiotic persistence; bladder organoids; intracellular bacterial colonies; neutrophils; quiescent intracellular reservoirs; serial block-face scanning electron microscopy (SBEM); time-lapse microscopy; uropathogenic Escherichia coli.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Similar articles
-
Dynamic persistence of UPEC intracellular bacterial communities in a human bladder-chip model of urinary tract infection.Elife. 2021 Jul 5;10:e66481. doi: 10.7554/eLife.66481. Elife. 2021. PMID: 34219648 Free PMC article.
-
Distinct Morphological Fates of Uropathogenic Escherichia coli Intracellular Bacterial Communities: Dependency on Urine Composition and pH.Infect Immun. 2020 Aug 19;88(9):e00884-19. doi: 10.1128/IAI.00884-19. Print 2020 Aug 19. Infect Immun. 2020. PMID: 32540870 Free PMC article.
-
Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection.Infect Immun. 2011 Oct;79(10):4250-9. doi: 10.1128/IAI.05339-11. Epub 2011 Aug 1. Infect Immun. 2011. PMID: 21807904 Free PMC article.
-
Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8829-35. doi: 10.1073/pnas.97.16.8829. Proc Natl Acad Sci U S A. 2000. PMID: 10922042 Free PMC article. Review.
-
Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.FEMS Microbiol Rev. 2012 May;36(3):616-48. doi: 10.1111/j.1574-6976.2012.00339.x. FEMS Microbiol Rev. 2012. PMID: 22404313 Free PMC article. Review.
Cited by
-
Nur77 protects the bladder urothelium from intracellular bacterial infection.Nat Commun. 2024 Sep 27;15(1):8308. doi: 10.1038/s41467-024-52454-8. Nat Commun. 2024. PMID: 39333075 Free PMC article.
-
Organoids as Innovative Models for Bone and Joint Diseases.Cells. 2023 Jun 8;12(12):1590. doi: 10.3390/cells12121590. Cells. 2023. PMID: 37371060 Free PMC article. Review.
-
Farm and Companion Animal Organoid Models in Translational Research: A Powerful Tool to Bridge the Gap Between Mice and Humans.Front Med Technol. 2022 May 12;4:895379. doi: 10.3389/fmedt.2022.895379. eCollection 2022. Front Med Technol. 2022. PMID: 35647577 Free PMC article. Review.
-
Metabolic flux regulates growth transitions and antibiotic tolerance in uropathogenic Escherichia coli.J Bacteriol. 2024 Jun 20;206(6):e0016224. doi: 10.1128/jb.00162-24. Epub 2024 May 30. J Bacteriol. 2024. PMID: 38814092 Free PMC article.
-
Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics.Nat Rev Microbiol. 2025 Feb;23(2):72-86. doi: 10.1038/s41579-024-01092-4. Epub 2024 Sep 9. Nat Rev Microbiol. 2025. PMID: 39251839 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
